Cardiol Therapeutics Inc. (TSX: CRDL)
Health Care · Pharmaceuticals · CA
CA$1.78
-12.32% today · +21.9% 1Y
Cardiol Therapeutics Inc. (TSX: CRDL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $145.74M and employs 18 people.
Over the last twelve months the share price has gained 21.9%, trading between 1.23 and 3.23.
Tweenvest scores Cardiol Therapeutics Inc. across four factors: quality 38/100, value 89/100. Its strongest factor is value.
CRDL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $145.74M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.34
- Dividend yield
- —
- Beta (5Y)
- 0.73
- 52-week high
- CA$3.23
- 52-week low
- CA$1.23
- Avg volume (3M)
- —
- Shares outstanding
- 116.82M
- Employees
- 18
- Next earnings
- —
About Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
- ISIN
- CA14161Y2006
- Founded
- 2017
- Listed since
- Dec 20, 2018
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Memphis Pharmaceuticals & Chemical IndustriesCASE: MPCI | $150.31M | EGP346.01 | -0.14% |
| BINEX Co., Ltd.KOSDAQ: A053030 | $150.19M | ₩6,340.00 | -1.09% |
| Panion & Bf Biotech Inc.TWSE: 1760 | $149.36M | NT$55.70 | +2.01% |
| TTK Healthcare LimitedBSE: 507747 | $149.19M | Rs1,021.85 | +0.74% |
| Quality Chemical Industries LimitedUGSE: QCIL | $144.58M | USh161.88 | +0.55% |
| BGM Group Ltd.NasdaqCM: BGM | $143.56M | $10.75 | +15.10% |
| Alexandria Co. For Pharmaceuticals & Chemical IndustriesCASE: AXPH | $142.80M | EGP1,495.64 | -0.76% |
| PT Pyridam Farma TbkIDX: PYFA | $141.92M | Rp226.00 | +14.14% |
Figures last refreshed Oct 11, 2026.